塩野義製薬、米国のバイオ医薬品企業を買収へ 3155億円で
We haven't written up this one. The Asahi Shimbun has the full story — the link below goes straight to it.
This story
This is one outlet's version. Read the fullest account.
- 塩野義製薬、米国のバイオ医薬品企業を買収へ 3155億円で asahi.com
More in World
Suburban development pitched as reconciliation act sees developers taking helm of Indigenous partner corporation
A new community in southeast Ottawa was sold as a unique chance for reconciliation with Algonquin people, but it turns out the Algonquin corporation partnering with Taggart Group is now led by the…
Court sends Bergstan’s Cape Town tender appeal back for review
The Western Cape High Court set aside the City of Cape Town’s internal appeal decision and ordered its Appeal Authority to reconsider Bergstan’s arguments, while leaving the original tender decisions…
Hong Kong lawmakers say 5-year tax incentive too short to entice major innovative firms
Hong Kong lawmakers have backed the government’s proposed tax incentives for large innovative companies, but many said on Monday that the planned five-year concession period is too short to attract…
Trial set to begin for man accused in massive gold heist at Toronto’s Pearson airport
BRAMPTON — A trial is set to begin today in Brampton, Ont., for a man accused in what investigators have called one of the largest gold heists in Canadian history.